Skip to main content

Table 1 Basic features of the publications included in this meta-analysis (n = 20)

From: High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis

    cancer type No. of patients BANCR expression detection method survival analysis   HR statistics hazard ratios (95% CI) follow-up (month)
Study (Reference) year country high low cut-off
    total LNM HTS DM total LNM HTS DM  
Guo Q [34] 2014 China CRC 60 18 14 16 42 13 16 qRT-PCR OS mean-value NA NA NA
He A [30] 2016 China Bladder cancer 54 19 1 9 35 3 30 qRT-PCR OS NA NA NA NA
Liu T [27] 2018 China PTC 30 17 4 13 6 qRT-PCR OS mean-value directly NA 60
Li L [12] 2015 China GC 184 92 60 67 12 92 43 51 0 qRT-PCR OS median directly 1.511(1.025–2.227) 100
Liao T [24] 2017 China PTC 92 29 14 4 63 30 22 qRT-PCR NA NA NA NA
Liu Z [35] 2016 China ESCC 142 71 57 41 30 71 33 23 19 qRT-PCR OS median directly 2.24(1.05–4.76) 60
DFS median directly 3.45(1.92–6.20)
Lou K [33] 2018 China BC 65 34 24 18 31 13 6 qRT-PCR OS NA SC 1.39(0.86–2.25) 120
DFS 1.48(0.83–2.64)
Shen X [29] 2017 China CRC 116 53 32 53 17 qRT-PCR OS median directly 2.24(1.22–4.11) 70
Sun M [19] 2014 China NSCLC 113 53 19 11 60 40 30 qRT-PCR OS fold change SC 0.5(0.26–0.94) 40
DFS 0.34(0.18–0.64)
Wang D [36] 2016 China EC 30 15 6 7 15 1 1 qRT-PCR OS median NA NA NA
Wang H [37] 2016 China HCC 108 43 29 35 65 23 20 qRT-PCR OS mean-value NA NA NA
Jiang J [32] 2018 China BC 216 125 63 60   91 17 18   qRT-PCR OS median NA 1.585(1.298–1.935) 60
RFS 1.532(1.272–1.844)
Zhang J [26] 2018 China PTC 60 17 6 43 30 qRT-PCR OS NA NA NA NA
Sadeghpour [22] 2018 Iran ESCC 150 75 38 41 75 17 10 qRT-PCR OS NA NA NA NA
Peng Z [23] 2015 China Osteosarcoma 84 42 30 20 42 16 14 qRT-PCR OS median directly 2.934(1.12–7.67) 60
Zhao N [16] 2018 China HCC 46 23 7 23 4 qRT-PCR OS mean-value NA NA NA
Zhou T [17] 2016 China HCC 109 54 37 55 21 qRT-PCR OS median SC 4.24(1.32–13.61) 60
Su S [38] 2015 China retinoblastoma 60 30 30 qRT-PCR OS median directly 2.9(1.05–8.03) 60
Xue S [18] 2018 China ccRCC 62 qRT-PCR OS NA SC 0.77(0.24–2.47) 60
Chen Q [39] 2018 China ESCC 80 39 30 41 16 qRT-PCR NA median NA NA
  1. Note. BRAF-activated noncoding RNA; No. Number; Total: total patients in high expression group or low expression group; NSCLC Non-small cell lung cancer; HCC Hepatocellular carcinoma; CRC Colorectal cancer; BL Bladder cancer; BC Breast cancer; ccRCC Clear cell renal cell carcinoma; GC Gastric cancer; LNM Lymphatic node metastasis; DM Distant metastasis; HTS High tumor stage (III,IV); NA Not available; qRT-PCR Quantitative reverse transcription-polymerase chain reaction; ESCC Esophagus cancer; EC Endometrial Cancer; SC Survival curve; directly: HR was extracted dirrectly from article; PTC Thyroid Carcinoma; OS Overall survival; DFS Disease free survival; RFS Recurrence free survival